Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Dec;55(12):888–894. doi: 10.1136/ard.55.12.888

Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.

Y T Konttinen 1, A Ceponis 1, S Meri 1, A Vuorikoski 1, P Kortekangas 1, T Sorsa 1, A Sukura 1, S Santavirta 1
PMCID: PMC1010340  PMID: 9014582

Abstract

OBJECTIVES: To investigate the role of complement cascade induced damage and protection against it in acute arthritides compared to rheumatoid arthritis and other chronic joint derangements. METHODS: C3c, C9, and protectin (CD59) were examined by avidin-biotin-peroxidase complex staining. RESULTS: Marked deposits of C3c and C9 were found in synovial vasculature and intercellular matrix of the lining in rheumatoid arthritis and in acute arthritides (including bacterial, reactive, and osteoarthritis flare up). Furthermore, protectin was not visible in synovial lining cells and was relatively weakly expressed in stromal and endothelial cells in rheumatoid arthritis; also in acute arthritides protectin expression was weak. In contrast, C3c and C9 deposits were not found in chronic conditions associated with degenerative diseases (osteoarthritis and osteochondritis dissecans) or mechanical causes (patellar luxation and a ruptured meniscus), in which also the protectin expression was prominent in synovial lining, endothelial and some stromal cells. CONCLUSIONS: Activation of the complement in rheumatoid arthritis and in acute arthritides seems to be associated with a decreased protection of synovial cells against cellular effects and lysis mediated by membrane attack complex.

Full text

PDF
888

Images in this article

891Image
on p.891
892Image
on p.892

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., Christy W., Cooke T. D., Greenwald R., Hochberg M. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986 Aug;29(8):1039–1049. doi: 10.1002/art.1780290816. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Baker D. G., Schumacher H. R., Jr Acute monoarthritis. N Engl J Med. 1993 Sep 30;329(14):1013–1020. doi: 10.1056/NEJM199309303291407. [DOI] [PubMed] [Google Scholar]
  4. Bjørge L., Jensen T. S., Ulvestad E., Vedeler C. A., Matre R. The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29. Scand J Immunol. 1995 Apr;41(4):350–356. doi: 10.1111/j.1365-3083.1995.tb03578.x. [DOI] [PubMed] [Google Scholar]
  5. Brodeur J. P., Ruddy S., Schwartz L. B., Moxley G. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Dec;34(12):1531–1537. doi: 10.1002/art.1780341209. [DOI] [PubMed] [Google Scholar]
  6. Corvetta A., Pomponio G., Rinaldi N., Luchetti M. M., Di Loreto C., Stramazzotti D. Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):433–438. [PubMed] [Google Scholar]
  7. Dalmasso A. P., Falk R. J., Raij L. The pathobiology of the terminal complement complexes. Complement Inflamm. 1989;6(1):36–48. doi: 10.1159/000463070. [DOI] [PubMed] [Google Scholar]
  8. Daniels R. H., Houston W. A., Petersen M. M., Williams J. D., Williams B. D., Morgan B. P. Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology. 1990 Feb;69(2):237–242. [PMC free article] [PubMed] [Google Scholar]
  9. Davies A., Simmons D. L., Hale G., Harrison R. A., Tighe H., Lachmann P. J., Waldmann H. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med. 1989 Sep 1;170(3):637–654. doi: 10.1084/jem.170.3.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davies M. E., Horner A., Loveland B. E., McKenzie I. F. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease. Scand J Rheumatol. 1994;23(6):316–321. doi: 10.3109/03009749409099280. [DOI] [PubMed] [Google Scholar]
  11. Doherty M., Richards N., Hornby J., Powell R. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis. 1988 Mar;47(3):190–197. doi: 10.1136/ard.47.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Guc D., Gulati P., Lemercier C., Lappin D., Birnie G. D., Whaley K. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium. Rheumatol Int. 1993;13(4):139–146. doi: 10.1007/BF00301260. [DOI] [PubMed] [Google Scholar]
  13. Hakulinen J., Meri S. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Lab Invest. 1994 Dec;71(6):820–827. [PubMed] [Google Scholar]
  14. Hattori R., Hamilton K. K., McEver R. P., Sims P. J. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem. 1989 May 25;264(15):9053–9060. [PubMed] [Google Scholar]
  15. Holguin M. H., Wilcox L. A., Bernshaw N. J., Rosse W. F., Parker C. J. Erythrocyte membrane inhibitor of reactive lysis: effects of phosphatidylinositol-specific phospholipase C on the isolated and cell-associated protein. Blood. 1990 Jan 1;75(1):284–289. [PubMed] [Google Scholar]
  16. Jahn B., Von Kempis J., Krämer K. L., Filsinger S., Hänsch G. M. Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA. Immunology. 1993 Feb;78(2):329–334. [PMC free article] [PubMed] [Google Scholar]
  17. Johnson A. R., Hugli T. E., Müller-Eberhard H. J. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 1975 Jun;28(6):1067–1080. [PMC free article] [PubMed] [Google Scholar]
  18. Jose P. J., Moss I. K., Maini R. N., Williams T. J. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis. 1990 Oct;49(10):747–752. doi: 10.1136/ard.49.10.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kemp P. A., Spragg J. H., Brown J. C., Morgan B. P., Gunn C. A., Taylor P. W. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J Clin Lab Immunol. 1992;37(4):147–162. [PubMed] [Google Scholar]
  20. Meri S., Waldmann H., Lachmann P. J. Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest. 1991 Nov;65(5):532–537. [PubMed] [Google Scholar]
  21. Mollnes T. E., Lea T., Mellbye O. J., Pahle J., Grand O., Harboe M. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. Arthritis Rheum. 1986 Jun;29(6):715–721. doi: 10.1002/art.1780290603. [DOI] [PubMed] [Google Scholar]
  22. Morgan B. P., Daniels R. H., Watts M. J., Williams B. D. In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol. 1988 Sep;73(3):467–472. [PMC free article] [PubMed] [Google Scholar]
  23. Ninomiya H., Sims P. J. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9. J Biol Chem. 1992 Jul 5;267(19):13675–13680. [PubMed] [Google Scholar]
  24. Olmez U., Garred P., Mollnes T. E., Harboe M., Berntzen H. B., Munthe E. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. Scand J Rheumatol. 1991;20(3):183–189. doi: 10.3109/03009749109103019. [DOI] [PubMed] [Google Scholar]
  25. Prehm P. Synovial hyaluronate in rheumatoid arthritis binds C1q and is covalently bound to antibodies: a model for chronicity. Ann Rheum Dis. 1995 May;54(5):408–412. doi: 10.1136/ard.54.5.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rey-Millet C. A., Chesne S., Colomb M. G. Associated complement C3b. Towards an understanding of its intracellular modifications. Mol Immunol. 1993 Jul;30(10):855–864. doi: 10.1016/0161-5890(93)90009-z. [DOI] [PubMed] [Google Scholar]
  27. Rumfeld W. R., Morgan B. P., Campbell A. K. The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseases. Br J Rheumatol. 1986 Aug;25(3):266–270. doi: 10.1093/rheumatology/25.3.266. [DOI] [PubMed] [Google Scholar]
  28. Sanders M. E., Kopicky J. A., Wigley F. M., Shin M. L., Frank M. M., Joiner K. A. Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. J Rheumatol. 1986 Dec;13(6):1028–1034. [PubMed] [Google Scholar]
  29. Schifferli J. A., Ng Y. C., Peters D. K. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med. 1986 Aug 21;315(8):488–495. doi: 10.1056/NEJM198608213150805. [DOI] [PubMed] [Google Scholar]
  30. Schwartz L. B., Kawahara M. S., Hugli T. E., Vik D., Fearon D. T., Austen K. F. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol. 1983 Apr;130(4):1891–1895. [PubMed] [Google Scholar]
  31. Seifert P. S., Roth I., Schmiedt W., Oelert H., Okada N., Okada H., Bhakdi S. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions. Atherosclerosis. 1992 Oct;96(2-3):135–145. doi: 10.1016/0021-9150(92)90060-t. [DOI] [PubMed] [Google Scholar]
  32. Venneker G. T., Das P. K., Meinardi M. M., van Marle J., van Veen H. A., Bos J. D., Asghar S. S. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins are constitutively down-regulated in psoriatic skin. J Pathol. 1994 Feb;172(2):189–197. doi: 10.1002/path.1711720206. [DOI] [PubMed] [Google Scholar]
  33. Venneker G. T., van den Hoogen F. H., Boerbooms A. M., Bos J. D., Asghar S. S. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage. Lab Invest. 1994 Jun;70(6):830–835. [PubMed] [Google Scholar]
  34. Väkevä A., Laurila P., Meri S. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest. 1992 Nov;67(5):608–616. [PubMed] [Google Scholar]
  35. Väkevä A., Laurila P., Meri S. Regulation of complement membrane attack complex formation in myocardial infarction. Am J Pathol. 1993 Jul;143(1):65–75. [PMC free article] [PubMed] [Google Scholar]
  36. Walsh L. A., Tone M., Thiru S., Waldmann H. The CD59 antigen--a multifunctional molecule. Tissue Antigens. 1992 Nov;40(5):213–220. doi: 10.1111/j.1399-0039.1992.tb02048.x. [DOI] [PubMed] [Google Scholar]
  37. Yuan F. F., Bryant J. A., Fletcher A. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells. Immunol Cell Biol. 1995 Feb;73(1):66–72. doi: 10.1038/icb.1995.11. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES